Sterilizing Immunity against COVID-19: Developing Helper T cells I and II activating vaccines is imperative

Six months after the publication of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) sequence, a record number of vaccine candidates were listed, and quite a number of them have since been approved for emergency use against the novel coronavirus disease 2019 (COVID-19). This unpreced...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

Isaac Kyei-Barffour [verfasserIn]

Samuel Akwetey Addo [verfasserIn]

Enoch Aninagyei [verfasserIn]

George Ghartey-Kwansah [verfasserIn]

Desmond Omane Acheampong [verfasserIn]

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2021

Schlagwörter:

Sterilizing immunity

Adaptive immune response

COVID-19

SARS-CoV-2

Antigen

Reverse vaccinology

Übergeordnetes Werk:

In: Biomedicine & Pharmacotherapy - Elsevier, 2021, 144(2021), Seite 112282-

Übergeordnetes Werk:

volume:144 ; year:2021 ; pages:112282-

Links:

Link aufrufen
Link aufrufen
Link aufrufen
Journal toc

DOI / URN:

10.1016/j.biopha.2021.112282

Katalog-ID:

DOAJ075187744

Nicht das Richtige dabei?

Schreiben Sie uns!